(Q44265199)

English

Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with Type 1 diabetes

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with Type 1 diabetes (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

type-1 diabetes

0 references

0 references

author name string

Junnosuke Miura

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Sho ichi Yamagishi

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Yasuko Uchigata

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Masayoshi Takeuchi

4

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Hiroshi Yamamoto

5

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Zenji Makita

6

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Yasuhiko Iwamoto

7

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 2003

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Journal of Diabetes and its Complications

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

16-21

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Formation of immunochemical advanced glycosylation end products precedes and correlates with early manifestations of renal and retinal disease in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900183-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900183-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The advanced glycation end product, Nepsilon-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900183-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Diabetic retinopathy risk correlates with intracellular concentrations of the glycoxidation product Nepsilon-(carboxymethyl) lysine independently of glycohaemoglobin concentrations.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900183-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A sensitive and specific ELISA for plasma pentosidine

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900183-6

7 January 2021

based on heuristic

inferred from DOI database lookup

N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900183-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900183-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Advanced glycosylation end products in patients with diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900183-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The relationship between accumulation of advanced glycation end products and expression of vascular endothelial growth factor in human diabetic retinas

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900183-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Advanced glycation end products: a Nephrologist's perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900183-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Upregulation of retinal vascular endothelial growth factor mRNAs in spontaneously diabetic rats without ophthalmoscopic retinopathy. A possible participation of advanced glycation end products in the development of the early phase of diabetic retino

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900183-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900183-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900183-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900183-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Advanced glycation endproducts inhibit prostacyclin production and induce plasminogen activator inhibitor-1 in human microvascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900183-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Receptor-Mediated Toxicity to Pericytes of Advanced Glycosylation End Products: A Possible Mechanism of Pericyte Loss in Diabetic Microangiopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900183-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Advanced glycation end products-driven angiogenesis in vitro. Induction of the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900183-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1056-8727(02)00183-6

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44265199&oldid=2108995605"